InfuSystem Enters Negative Pressure Wound Therapy Market

InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment (“DME”) manufacturers and health care providers, announced today that it has entered into an agreement whereby it will add Negative Pressure Wound Therapy (“NPWT”) to its Integrated Therapy Service (“ITS”) platform.  As part of the new relationship, InfuSystem’s turnkey solutions will include providing the durable medical equipment, overseeing logistics, biomedical services, and managing third-party billing.

Richard DiIorio, chief executive officer of InfuSystem, said, “We are pleased to announce the addition of NPWT to the Integrated Therapy Services platform, joining our existing therapies, oncology and pain management.  This addition results from a premier global health care services company seeking out InfuSystem and our unique expertise in providing clinic-to-home DME solutions.  The core market to be targeted under the new agreement is U.S. home health care, which as a subset of the broader NPWT market, has an estimated addressable market of $600 million per year.”

“We are excited to collaborate with a Top-10 health care services company on this new therapy and we look forward to a long and successful relationship,” Mr. DiIorio continued.  “As seen with past new business wins, the nature of our ITS business involves an initial period of on-boarding the participating facilities.  We will soon begin that on-boarding, but we do not expect to see meaningful revenue from NPWT until the second half of this year.  It should be noted that NPWT was not part of the Company’s previously announced full-year 2020 financial guidance.  We plan to update this guidance in the coming quarters,” concluded Mr. DiIorio.

Negative Pressure Wound Therapy (“NPWT”) is a therapeutic technique using vacuum dressing to promote healing of acute and chronic wounds.  Examples of acute wounds treated include those from surgery and c-sections, and chronic wounds treated include pressure ulcers, trophic, and vascular ulcers.  The U.S. market for NPWT therapy is estimated to exceed $2 billion by 2024.

https://finance.yahoo.com/news/infusystem-enters-negative-pressure-wound-113010550.html